Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304M Buy
3,901,694
+542,024
+16% +$43.7M 1.51% 13
2026
Q1
$292M Buy
3,359,670
+825,879
+33% +$79.1M 1.51% 12
2025
Q4
$243M Sell
2,533,791
-308,431
-11% -$30M 1.25% 23
2025
Q3
$270M Sell
2,842,222
-230,247
-7% -$21.2M 1.44% 15
2025
Q2
$267M Buy
3,072,469
+554,582
+22% +$47M 1.47% 15
2025
Q1
$227M Sell
2,517,887
-158,268
-6% -$14.2M 1.08% 16
2024
Q4
$214M Sell
2,676,155
-37,508
-1% -$3.25M 1.32% 17
2024
Q3
$244M Sell
2,713,663
-139,912
-5% -$11.8M 0.88% 19
2024
Q2
$225M Sell
2,853,575
-125,273
-4% -$10.3M 0.89% 15
2024
Q1
$259M Buy
+2,978,848
New +$254M 0.98% 12

Other funds holding MDT

M&G plc's MDT Position: Q2 2026 in Review

M&G plc increased its Medtronic (MDT) stake by 16% in Q2 2026, buying an estimated $43.7M and bringing the position to 3,901,694 shares worth $304M. The position accounts for 1.51% of the portfolio, ranked #13.

M&G plc first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • M&G plc held 3,901,694 shares of Medtronic worth $304M as of Q2 2026.
  • M&G plc bought 542,024 Medtronic shares in Q2 2026, an estimated $43.7M.
  • Medtronic made up 1.51% of M&G plc's portfolio in Q2 2026, its #13 holding.
  • M&G plc first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.